AKBARI, O., PANJWANI, N., GARCIA, S., TASCON, R., LOWRIE, D. & STOCKINGER, B. (1999). DNA
vaccination: transfection and activation of dendritic cells as key events for immunity. J
Exp Med 189, 169-78.
ALISKY, J. M., HUGHES, S. M. & DAVIDSON, B. L. (2003). Transduction of neurons lining the
cerebral external capsules in mice with feline immunodeficiency virus based vectors.
Neurosci Lett 351, 120-4.
BAEKELANDT, V., CLAEYS, A., EGGERMONT, K., LAUWERS, E., DE STROOPER, B., NUTTIN, B. & DEBYSER,
Z. (2002). Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Hum Gene Ther 13, 841-53.
BENDINELLI, M., PISTELLO, M., DEL MAURO, D., CAMMAROTA, G., MAGGI, F., LEONILDI, A.,
GIANNECCHINI, S., BERGAMINI, C. & MATTEUCCI, D. (2001). During readaptation in vivo, a
tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein. J Virol 75, 4584-93.
BERTOLACCINI, L. & OLIVERO, G. (2001). [Cancer immunotherapy. A future therapeutical
choice?]. Minerva Chir 56, 183-91.
BIGORNIA, L., LOCKRIDGE, K. M. & SPARGER, E. E. (2001). Construction and in vitro
characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses. J Virol 75, 1054-60.
BLAESE, R. M., CULVER, K. W., MILLER, A. D., CARTER, C. S., FLEISHER, T., CLERICI, M., SHEARER, G.,
CHANG, L., CHIANG, Y., TOLSTOSHEV, P. & ET AL. (1995). T lymphocyte-directed gene
therapy for ADA- SCID: initial trial results after 4 years. Science 270, 475-80.
BROSSART, P., GOLDRATH, A. W., BUTZ, E. A., MARTIN, S. & BEVAN, M. J. (1997). Virus-mediated
delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol
158, 3270-6.
BROWNING, M. T., MUSTAFA, F., SCHMIDT, R. D., LEW, K. A. & RIZVI, T. A. (2003). Sequences
within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation. Virus Res 93, 199-209.
BUKRINSKY, M. I., HAGGERTY, S., DEMPSEY, M. P., SHAROVA, N., ADZHUBEL, A., SPITZ, L., LEWIS, P.,
GOLDFARB, D., EMERMAN, M. & STEVENSON, M. (1993). A nuclear localization signal within
HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-9. BURKHARD, M. J. & DEAN, G. A. (2003). Transmission and immunopathogenesis of FIV in cats as
a model for HIV. Curr HIV Res 1, 15-29.
CHARNEAU, P., MIRAMBEAU, G., ROUX, P., PAULOUS, S., BUC, H. & CLAVEL, F. (1994). HIV-1 reverse
CHATTERJI, U., GRANT, C. K. & ELDER, J. H. (2000). Feline immunodeficiency virus Vif localizes to
the nucleus. J Virol 74, 2533-40.
CONDIOTTI, R., CURRAN, M. A., NOLAN, G. P., GILADI, H., KETZINEL-GILAD, M., GROSS, E. & GALUN, E.
(2004). Prolonged liver-specific transgene expression by a non-primate lentiviral vector.
Biochem Biophys Res Commun 320, 998-1006.
CONSIGLIO, A., QUATTRINI, A., MARTINO, S., BENSADOUN, J. C., DOLCETTA, D., TROJANI, A., BENAGLIA,
G., MARCHESINI, S., CESTARI, V., OLIVERIO, A., BORDIGNON, C. & NALDINI, L. (2001). In vivo
gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med
7, 310-6.
CURRAN, M. A., KAISER, S. M., ACHACOSO, P. L. & NOLAN, G. P. (2000). Efficient transduction of
nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther 1, 31-8. ELDER, J. H., DEAN, G. A., HOOVER, E. A., HOXIE, J. A., MALIM, M. H., MATHES, L., NEIL, J. C.,
NORTH, T. W., SPARGER, E., TOMPKINS, M. B., TOMPKINS, W. A., YAMAMOTO, J., YUHKI, N.,
PEDERSEN, N. C. & MILLER, R. H. (1998). Lessons from the cat: feline immunodeficiency
virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 14, 797-801.
ESSLINGER, C., CHAPATTE, L., FINKE, D., MICONNET, I., GUILLAUME, P., LEVY, F. & MACDONALD, H. R.
(2003). In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J Clin Invest 111, 1673-81.
ESSLINGER, C., ROMERO, P. & MACDONALD, H. R. (2002). Efficient transduction of dendritic cells
and induction of a T-cell response by third-generation lentivectors. Hum Gene Ther 13, 1091-100.
FELBER, B. K., HADZOPOULOU-CLADARAS, M., CLADARAS, C., COPELAND, T. & PAVLAKIS, G. N. (1989).
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci U S A 86, 1495-9.
FILLEY, C. M. (1998). The behavioral neurology of cerebral white matter. Neurology 50,
1535-40.
FINK, D. J., GLORIOSO, J. & MATA, M. (2003). Therapeutic gene transfer with herpes-based
vectors: studies in Parkinson's disease and motor nerve regeneration. Exp Neurol 184
Suppl 1, S19-24.
FRIEDMANN, T. & YEE, J. K. (1995). Pseudotyped retroviral vectors for studies of human gene
therapy. Nat Med 1, 275-7.
GASMI, M., GLYNN, J., JIN, M. J., JOLLY, D. J., YEE, J. K. & CHEN, S. T. (1999). Requirements for
efficient production and transduction of human immunodeficiency virus type 1-based vectors. J Virol 73, 1828-34.
GEER, C. P. & GROSSMAN, S. A. (1997). Interstitial fluid flow along white matter tracts: a
potentially important mechanism for the dissemination of primary brain tumors. J
Neurooncol 32, 193-201.
GEMENIANO, M. C., SAWAI, E. T., LEUTENEGGER, C. M. & SPARGER, E. E. (2003). Feline
immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity. J Virol 77, 8819-30.
GEMENIANO, M. C., SAWAI, E. T. & SPARGER, E. E. (2004). Feline immunodeficiency virus Orf-A
localizes to the nucleus and induces cell cycle arrest. Virology 325, 167-74.
GRAF, M., BOJAK, A., DEML, L., BIELER, K., WOLF, H. & WAGNER, R. (2000). Concerted action of
multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J Virol 74, 10822-6.
GRAHAM, F. L. & PREVEC, L. (1995). Methods for construction of adenovirus vectors. Mol Biotechnol 3, 207-20.
HEISTER, T. G., VOGTLIN, A., MULLER, L., HEID, I. & FRAEFEL, C. (2004). Construction of HSV-1
BACs and their use for packaging of HSV-1-based amplicon vectors. Methods Mol Biol
256, 241-56.
HENDERSON, B. R. & PERCIPALLE, P. (1997). Interactions between HIV Rev and nuclear import
and export factors: the Rev nuclear localisation signal mediates specific binding to human importin-beta. J Mol Biol 274, 693-707.
JOHNSTON, J. & POWER, C. (1999). Productive infection of human peripheral blood mononuclear
cells by feline immunodeficiency virus: implications for vector development. J Virol 73, 2491-8.
JOHNSTON, J. C., GASMI, M., LIM, L. E., ELDER, J. H., YEE, J. K., JOLLY, D. J., CAMPBELL, K. P.,
DAVIDSON, B. L. & SAUTER, S. L. (1999). Minimum requirements for efficient transduction
of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 73, 4991-5000.
KORDOWER, J. H., EMBORG, M. E., BLOCH, J., MA, S. Y., CHU, Y., LEVENTHAL, L., MCBRIDE, J., CHEN,
E. Y., PALFI, S., ROITBERG, B. Z., BROWN, W. D., HOLDEN, J. E., PYZALSKI, R., TAYLOR, M. D.,
CARVEY, P., LING, Z., TRONO, D., HANTRAYE, P., DEGLON, N. & AEBISCHER, P. (2000).
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-73.
KOZAK, S. L., SIESS, D. C., KAVANAUGH, M. P., MILLER, A. D. & KABAT, D. (1995). The envelope
glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J Virol 69, 3433-40.
KYRKANIDES, S., MILLER, J. H. & FEDEROFF, H. J. (2003). Systemic FIV vector administration:
transduction of CNS immune cells and Purkinje neurons. Brain Res Mol Brain Res 119, 1-9.
LIN, Y. L., NOEL, D., METTLING, C., REANT, B., CLOT, J., JORGENSEN, C. & CORBEAU, P. (2004). Feline
immunodeficiency virus vectors for efficient transduction of primary human
synoviocytes: application to an original model of rheumatoid arthritis. Hum Gene Ther
15, 588-96.
LOCKRIDGE, K. M., HIMATHONGKHAM, S., SAWAI, E. T., CHIENAND, M. & SPARGER, E. E. (1999). The
feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology 261, 25-30.
LOEWEN, N., LESKE, D. A., CAMERON, J. D., CHEN, Y., WHITWAM, T., SIMARI, R. D., TEO, W. L.,
FAUTSCH, M. P., POESCHLA, E. M. & HOLMES, J. M. (2004). Long-term retinal transgene
expression with FIV versus adenoviral vectors. Mol Vis 10, 272-80.
LOMBARDI, S., GARZELLI, C., PISTELLO, M., MASSI, C., MATTEUCCI, D., BALDINOTTI, F., CAMMAROTA, G., DA PRATO, L., BANDECCHI, P., TOZZINI, F. & ET AL. (1994). A neutralizing antibody-inducing
peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J Virol 68, 8374-9.
MAGUIR-ZEIS, K. A., BOWERS, W. J. & FEDEROFF, H. J. (2001). HSV vector-mediated gene delivery
to the central nervous system. Curr Opin Mol Ther 3, 482-90.
MARCONI, P., KRISKY, D., OLIGINO, T., POLIANI, P. L., RAMAKRISHNAN, R., GOINS, W. F., FINK, D. J. &
GLORIOSO, J. C. (1996). Replication-defective herpes simplex virus vectors for gene
transfer in vivo. Proc Natl Acad Sci U S A 93, 11319-20.
MAY, C., RIVELLA, S., CHADBURN, A. & SADELAIN, M. (2002). Successful treatment of murine
beta-thalassemia intermedia by transfer of the human beta-globin gene. Blood 99, 1902-8. MILLER, A. D., MILLER, D. G., GARCIA, J. V. & LYNCH, C. M. (1993). Use of retroviral vectors for
gene transfer and expression. Methods Enzymol 217, 581-99.
MIYOSHI, H., BLOMER, U., TAKAHASHI, M., GAGE, F. H. & VERMA, I. M. (1998). Development of a
self-inactivating lentivirus vector. J Virol 72, 8150-7.
MOSCARDINI, M., PISTELLO, M., BENDINELLI, M., FICHEUX, D., MILLER, J. T., GABUS, C., LE GRICE, S.
F., SUREWICZ, W. K. & DARLIX, J. L. (2002). Functional interactions of nucleocapsid
protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J
NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F. H., VERMA, I. M. & TRONO, D.
(1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-7.
OTANI, K., NITA, I., MACAULAY, W., GEORGESCU, H. I., ROBBINS, P. D. & EVANS, C. H. (1996).
Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol
156, 3558-62.
PARKS, R. J., CHEN, L., ANTON, M., SANKAR, U., RUDNICKI, M. A. & GRAHAM, F. L. (1996). A
helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 93, 13565-70.
PAYNE, S. L. & ELDER, J. H. (2001). The role of retroviral dUTPases in replication and virulence. Curr Protein Pept Sci 2, 381-8.
PHILLIPS, T. R., LAMONT, C., KONINGS, D. A., SHACKLETT, B. L., HAMSON, C. A., LUCIW, P. A. &
ELDER, J. H. (1992). Identification of the Rev transactivation and Rev-responsive
elements of feline immunodeficiency virus. J Virol 66, 5464-71.
PISTELLO, M., MOSCARDINI, M., MAZZETTI, P., BONCI, F., ZACCARO, L., ISOLA, P., FREER, G., SPECTER,
S., MATTEUCCI, D. & BENDINELLI, M. (2002). Development of feline immunodeficiency
virus ORF-A (tat) mutants: in vitro and in vivo characterization. Virology 298, 84-95. POESCHLA, E. M. & LOONEY, D. J. (1998). CXCR4 is required by a nonprimate lentivirus:
heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J Virol 72, 6858-66.
POESCHLA, E. M., WONG-STAAL, F. & LOONEY, D. J. (1998). Efficient transduction of nondividing
human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4, 354-7. PRINCE, H. M. (1998). Gene transfer: a review of methods and applications. Pathology 30,
335-47.
REICHEL, M. B., BAINBRIDGE, J., BAKER, D., THRASHER, A. J., BHATTACHARYA, S. S. & ALI, R. R.
(2001). An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse. Br J Ophthalmol 85, 341-4.
ROBBINS, P. D. & GHIVIZZANI, S. C. (1998). Viral vectors for gene therapy. Pharmacol Ther 80,
35-47.
ROLLING, F. & SAMULSKI, R. J. (1995). AAV as a viral vector for human gene therapy. Generation
of recombinant virus. Mol Biotechnol 3, 9-15.
SAENZ, D. T. & POESCHLA, E. M. (2004). FIV: from lentivirus to lentivector. J Gene Med 6 Suppl 1, S95-104.
SHIMOJIMA, M., MIYAZAWA, T., IKEDA, Y., MCMONAGLE, E. L., HAINING, H., AKASHI, H., TAKEUCHI, Y.,
HOSIE, M. J. & WILLETT, B. J. (2004). Use of CD134 as a primary receptor by the feline
immunodeficiency virus. Science 303, 1192-5.
SINN, P. L., HICKEY, M. A., STABER, P. D., DYLLA, D. E., JEFFERS, S. A., DAVIDSON, B. L., SANDERS,
D. A. & MCCRAY, P. B., JR. (2003). Lentivirus vectors pseudotyped with filoviral envelope
glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 77, 5902-10.
TALBOTT, R. L., SPARGER, E. E., LOVELACE, K. M., FITCH, W. M., PEDERSEN, N. C., LUCIW, P. A. &
ELDER, J. H. (1989). Nucleotide sequence and genomic organization of feline
immunodeficiency virus. Proc Natl Acad Sci U S A 86, 5743-7.
THOMPSON, F. J., ELDER, J. & NEIL,J. C. (1994). Cis- and trans-regulation of feline
immunodeficiency virus: identification of functional binding sites in the long terminal repeat. J Gen Virol 75 ( Pt 3), 545-54.
TOMONAGA, K. & MIKAMI, T. (1996). Molecular biology of the feline immunodeficiency virus
auxiliary genes. J Gen Virol 77 ( Pt 8), 1611-21.
TOMONAGA, K., NORIMINE, J., SHIN, Y. S., FUKASAWA, M., MIYAZAWA, T., ADACHI, A., TOYOSAKI, T.,
KAWAGUCHI, Y., KAI, C. & MIKAMI, T. (1992). Identification of a feline immunodeficiency
virus gene which is essential for cell-free virus infectivity. J Virol 66, 6181-5.
VAISHNAV, Y. N., VAISHNAV, M. & WONG-STAAL, F. (1991). Identification and characterization of a
nuclear factor that specifically binds to the Rev response element (RRE) of human immunodeficiency virus type 1 (HIV-1). New Biol 3, 142-50.
VANDENDRIESSCHE, T., THORREZ, L., NALDINI, L., FOLLENZI, A., MOONS, L., BERNEMAN, Z., COLLEN, D.
& CHUAH, M. K. (2002). Lentiviral vectors containing the human immunodeficiency virus
type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100, 813-22.
WALTHER, W. & STEIN, U. (2000). Viral vectors for gene transfer: a review of their use in the
treatment of human diseases. Drugs 60, 249-71.
WANG, G., SINN, P. L., ZABNER, J. & MCCRAY, P. B., JR. (2002). Gene transfer to airway epithelia
using feline immunodeficiency virus-based lentivirus vectors. Methods Enzymol 346, 500-14.
WANG, Q. & FINER, M. H. (1996). Second-generation adenovirus vectors. Nat Med 2, 714-6.
WATERS, A. K., DE PARSEVAL, A. P., LERNER, D. L., NEIL, J. C., THOMPSON, F. J. & ELDER, J. H.
(1996). Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
WILLETT, B. J., CANNON, C. A. & HOSIE, M. J. (2003). Expression of CXCR4 on feline peripheral
blood mononuclear cells: effect of feline immunodeficiency virus infection. J Virol 77, 709-12.
WILSON, J. M., ENGELHARDT, J. F., GROSSMAN, M., SIMON, R. H. & YANG, Y. (1994). Gene therapy
of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial. Hum Gene
Ther 5, 501-19.
WU, N., WATKINS, S. C., SCHAFFER, P. A. & DELUCA, N. A. (1996). Prolonged gene expression and
cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol 70, 6358-69. YOU, Z., HUANG, X., HESTER, J., TOH, H. C. & CHEN, S. Y. (2001). Targeting dendritic cells to
enhance DNA vaccine potency. Cancer Res 61, 3704-11.
ZUFFEREY, R., DONELLO, J. E., TRONO, D. & HOPE, T. J. (1999). Woodchuck hepatitis virus
posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73, 2886-92.
ZUFFEREY, R., DULL, T., MANDEL, R. J., BUKOVSKY, A., QUIROZ, D., NALDINI, L. & TRONO, D. (1998).
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72, 9873-80.
